Empowering effective biomarker-driven precision oncology: A call to action
Mark LawlerPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, BT9 7AE, UK; Cancer Drug Development Forum, Clos Chapelle-aux-Champs 30, 1200 Brussels, Belgium. Electronic address: [email protected]Peter KeelingDiaceutics PLC, Health and Wellbeing Park, Kings Hall, First Floor Building Two, Dataworks at, 490 Lisburn Rd, BT9 6GU Belfast, UK. Electronic address: [email protected]Olga KholmanskikhFederal Agency for Medicines and Health Products, Galileelaan 5/03, 1210 Brussels, Belgium. Electronic address: [email protected]Warnyta MinnaardMissie Tumor Onbekend, Fannius Scholtenstraat 69H 1051 EV, Amsterdam, Netherlands. Electronic address: [email protected]Heike Moehlig-ZuttermeisterTÜV SÜD Product Service GmbH, Medical Health Services, Riedlerstraße 65, 80339 Munich, Germany. Electronic address: [email protected]Nicola NormannoIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via Piero Maroncelli, 40, 47014 Meldola, ItalyReena PhilipFood and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. Electronic address: [email protected]C. PoppF. Hoffmann-La Roche Ltd, Building 2, CH-4070 Basel, Switzerland. Electronic address: [email protected]Roberto SalgadoDepartment of Pathology, ZAS Hospitals, Lindendreef 1, 2020 Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Centre, 305 Grattan Street, Melbourne VIC 3052, Australia. Electronic address: [email protected]Ademi Santiago-WalkerJanssen Research & Development LLC, Johnson & Johnson Innovative Medicine, 1400 McKean Road, Spring House, PA 19477, USA. Electronic address: [email protected]Ana TrullasEuropean Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, the Netherlands. Electronic address: [email protected]Sahar Barjesteh van Waalwijk van Doorn-KhosrovaniDepartment of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, the Netherlands; CZ Health Insurance, Ringbaan West 236, 5038 KE Tilburg, the Netherlands. Electronic address: [email protected]Richard J. VartEli Lilly and Company Ltd, 8 Arlington Square West, Downshire Way, Bracknell, RG12 1PU, UK. Electronic address: [email protected]Jessica VermeulenJanssen Biologics B.V., a Johnson & Johnson company, Emmy Noetherweg 6, 2333 BK Leiden, the Netherlands. Electronic address: [email protected]Marianna VitaloniDigestive Cancers Europe, Rue de la Loi 235/27, 1040 Brussels, Belgium. Electronic address: [email protected]Jaap VerweijCancer Drug Development Forum, Clos Chapelle-aux-Champs 30, 1200 Brussels, Belgium. Electronic address: [email protected]
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 27